Want to join the conversation?
$EMN 2Q15 PR: Earnings outlook for the year improved due to record 2Q15 earnings & strong 1H15. Results reflect excellent performance of specialty businesses, including strong volume growth & product mix improvement. Eastman expects the momentum to continue into 2H15.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)